the cellular level and in animal models. Overall, the literature suggests that neural inflammation would be deleterious as well. Yet, studies translating these concepts 27 from animal to human physiology are scarce. The study by Okamoto et al. in this 28 issue is exemplary in that regard (10) . (1) . The observation that nicotine was more effective than 34 muscarine in inhibiting TNF release implicated nicotinic acetylcholine receptors.
35
Electrical vagus nerve stimulation during lethal endotoxinemia reduced systemic TNF 36 concentrations and prevented septic shock in rats (1) Interleukin-6 concentrations were increased compared with lean control women. In 85 fact, these measurements were similar to those in obese women without POTS.
86
Unlike in obese women with or without POTS, however, C reactive protein (CRP)
87
was not increased in lean POTS patients. The authors suggest that autonomic 88 mechanisms may have promoted interleukin-6 release from adipose tissue.
89
Previously, beta-adrenoreceptor stimulation with isoproterenol was shown to increase 90 interleukin-6 from isolated human adipocytes and in in vivo in human subjects (9).
5
Based on the dissociation between circulating interleukin-6, which stimulates 92 hepatic CRP release, and CRP concentrations in lean POTS patients, Okamoto et al. 93 speculate that the site in which interleukin-6 is produced may be important.
94
Interleukin-6 may have to be produced in visceral adipose tissue directly draining into 95 the portal circulation to elicit CRP release. The idea that norepinephrine/epinephrine 96 are important in sustaining low grade systemic inflammation is supported by 97 exceedingly rare patients with dopamine-beta-hydroxylase-deficiency, which is 98 required for converting dopamine to norepinephrine. Interleukin-6 levels were low in 99 these patients.
100
Obviously, studies in patients have their limitations and confounding variables, 101 such as differences in physical activity between groups, cannot be ignored. 
